№ lp_1_2_38242
File format: docx
Character count: 89911
File size: 163 KB
The document outlines interim quality standards for the National Bowel Screening Programme in New Zealand, focusing on quality assurance, monitoring, and evaluation processes for colorectal cancer screening.
Year:
2017
Region / city:
Wellington, New Zealand
Topic:
Bowel screening, quality standards
Document type:
Report
Institution:
Ministry of Health
Author:
National Screening Unit
Target audience:
Healthcare providers, quality monitoring groups
Validity period:
From 1 July 2017
Approval date:
July 2017
Revision date:
N/A
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Note:
Date of Protocol Creation
Topic:
Developmental Disabilities
Document Type:
Protocol
Agency:
Developmental Disabilities Administration (DDA)
Target Audience:
Caregivers, Medical Personnel
Context:
A protocol document detailing emergency procedures, signs, symptoms, and treatments related to bowel-related emergencies for individuals with developmental disabilities, along with guidelines for monitoring and medication.
Note:
Year
Theme:
Healthcare
Document Type:
Healthcare Plan
Note:
Year
Organization:
Aruma
Document type:
Care Plan / Health Management
Target audience:
Aruma staff, treating health professionals
Participant details:
Name, Date of birth, Preferred name, Aruma ID
Health condition details:
Diagnosis, Medication requirements, Risk factors for constipation or faecal incontinence, Presence of Autism or stoma
Diet and fluid management:
Instructions, Monitoring requirements
Bowel management:
Daily schedule, Stool appearance reference, Actions required, Supplies needed
Monitoring and recording:
Bowel chart usage, Effectiveness review, Shift reporting
Review timeline:
Scheduled review period, Next review date, Signs for immediate review
Emergency management:
Faecal incontinence, Chronic constipation, Urinary tract infection, Skin integrity risks, Autonomic dysreflexia
Context:
Clinical care document outlining individualized bowel management procedures, risk monitoring, and emergency responses for participants requiring high-intensity support.
Year:
2018
Region / City:
Milton Keynes
Theme:
Healthcare policy for spinal cord injury (SCI) care
Document type:
Policy
Organization:
Spinal Injuries Association
Author:
Carol Adcock, Debbie Green
Target audience:
Healthcare providers, clinical staff, NHS trusts
Review date:
January 2023
Approval date:
July 2018
Revision date:
January 2025
Year:
2023
Region / City:
New Zealand
Topic:
Bowel cancer screening, interval cancers, screening sensitivity
Document Type:
Report
Organization:
New Zealand Cancer Registry
Author:
Not specified
Target Audience:
Healthcare professionals, researchers
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2014
Region / city:
UK
Subject:
Nursing, Bowel Care
Document Type:
Assessment Tool
Organization / Institution:
NHSCT
Author:
Richmond, J P, Wright M E
Target Audience:
Healthcare professionals (nurses, doctors)
Date of approval:
January 2014
Date of modifications:
N/A
Year:
2019
Region / City:
Naas General Hospital
Topic:
Inflammatory Bowel Disease, Biologic Medication
Document Type:
Policy
Author:
Joanna Rea, Inflammatory Bowel Disease Clinical Nurse Specialist
Target Audience:
IBD CNSp, Gastroenterology team, nursing staff administering biologic medication
Approval Date:
14th January 2020
Revision Date:
January 2023
Version Number:
1
Supporting Evidence:
Infliximab, Remicade, Vedolizumab, Adalimumab, Imraldi, Amgevita, Hulio, Golimumab, Ustekinumab
Purpose:
Standardization of pre-screening and management of IBD patients requiring biologic treatment
Scope:
Biologic screening, patient education, IBD CNSp, gastroenterology team, nursing staff
Objective(s):
Ensure best practice for IBD patients on biologics
Outcome(s):
Clarity for staff on safe and evidence-based care for IBD patients on biologics
Governance:
IBD Working Group
Review Group:
Not Applicable
Date of Approval:
14th January 2020
Date of Next Revision:
January 2023
Year:
2015
Region / City:
Zurich, Switzerland
Topic:
Inflammatory bowel disease
Document type:
Journal Article
Organization / Institution:
University Hospital Zurich, University of California Riverside
Author:
Marianne R Spalinger, Declan F McCole, Gerhard Rogler, Michael Scharl
Target audience:
Researchers, medical professionals
Period of validity:
N/A
Approval date:
N/A
Modification date:
N/A
Year:
2010
Region / City:
Global
Document Type:
Medical Research Article
Organization / Institution:
Various Medical Institutions and Study Groups
Author:
Colombel JF, Sandborn WJ, Reinisch W, Mantzaris GJ, Kornbluth A, et al.
Target Audience:
Healthcare professionals, researchers
Period of Action:
2006-2012
Approval Date:
April 15, 2010
Modification Date:
N/A
Year:
2025
Region / City:
Leicester, Leicestershire and Rutland
Topic:
Bowel and bladder care for children and young people
Document Type:
Official correspondence
Organization / Institution:
Leicester, Leicestershire and Rutland Integrated Care Board (LLR ICB)
Author:
Corporate Governance Team, LLR ICB
Target Audience:
Public and relevant healthcare professionals
Period of Validity:
Not specified
Approval Date:
27 May 2025
Date of Modifications:
Not specified
Year:
2022
Region / city:
Australia
Topic:
Pharmacology, Drug Utilisation
Document type:
Research analysis
Organization:
Drug utilisation sub-committee (DUSC)
Author:
Not specified
Target audience:
Healthcare professionals, medical researchers
Period of validity:
Not specified
Date of approval:
1 October 2019
Date of revisions:
Not specified
Year:
2019
Country:
England
Subject:
Commissioning and provision of colorectal cancer services
Document type:
Clinical commissioning guidance
Issuing body:
Colorectal Cancer Clinical Expert Group
Chair:
Mr Michael Machesney, Consultant Colorectal Surgeon
Co-chair:
Mr John Griffith, Consultant Colorectal Surgeon
Audience:
Cancer Alliances; Commissioners; Acute Trusts; Patients and patient groups
Scope:
Whole patient pathway from first NHS contact to discharge from follow up or palliative care
Consulted organisations:
Association of Coloproctology of Great Britain and Ireland (ACPGBI); Bowel Cancer UK; Chemotherapy Clinical Reference Group; Hepatobiliary CRG; Radiotherapy CRG; Specialist Colorectal CRG; Thoracic Surgery CRG
Geographical coverage:
England
Review date:
Month XXXX
Date of issue:
Month XXXX
Year:
2023
Region / city:
United Kingdom
Topic:
Bowel cancer screening
Document type:
Leaflet
Organization / institution:
NHS
Author:
NHS
Target audience:
General public, individuals over 50
Period of validity:
Ongoing
Approval date:
N/A
Date of changes:
N/A
Name of Journal:
World Journal of Gastrointestinal Pathophysiology
Manuscript Type:
Topic Highlights
Year:
2015
Authors:
Sarah Ballou; Alyse Bedell; Laurie Keefer
Affiliation:
Division of Gastroenterology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, United States
Corresponding Author:
Sarah Ballou, MD
Region:
North America
Subject:
Irritable bowel syndrome; psychosocial impact; quality of life; comorbidity; cognitive behavioral therapy
Keywords:
Irritable bowel syndrome; Quality of life; Biopsychosocial; Burden of illness; Daily activities
Peer Review Status:
Fully peer-reviewed by external reviewers
Open Access Status:
Open-access under Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license
Conflict of Interest:
No conflicts of interest declared
Received Date:
April 28, 2015
Accepted Date:
August 25, 2015
Publisher:
Baishideng Publishing Group Inc.
Title of study:
Addressing unmet needs in adult inflammatory bowel disease care
Type of document:
Participant Information Sheet
Study type:
Online survey as part of a Doctor of Philosophy (PhD) Degree
Researcher:
Charlotte Playford
Supervisors:
Stephanie Armstrong; Zahid Asghar; Richard Ngomba; Andrew Rochford
Institution:
University of Lincoln
Collaborating organisation:
National Institute for Health Research (NIHR) Applied Research Collaboration (ARC) East Midlands
Country:
United Kingdom
Target participants:
Healthcare clinicians working within an IBD service in the United Kingdom
Sample size:
Approximately 10 participants
Data collection method:
Online survey and optional follow-up semi-structured interview
Data storage:
University OneDrive and secure university premises
Ethical approval reference:
2024_17184
Funder:
University of Lincoln; NIHR Applied Research Collaboration (ARC) East Midlands
Purpose:
Exploration of clinician perspectives on unmet needs and multidisciplinary care in adult IBD management
Confidentiality:
Anonymous data collection with optional identifiable follow-up consent
Withdrawal policy:
Withdrawal permitted before survey submission
Year:
2022
Region / City:
Coquitlam
Topic:
Request for Quotation
Document Type:
Form
Author:
City of Coquitlam
Target Audience:
Potential contractors and vendors
Period of Validity:
Until award of contract
Approval Date:
August 18, 2022
Date of Changes:
N/A
Year:
2020
Region / City:
United Kingdom
Topic:
Independent Legal Advice, Covid-19 restrictions
Document Type:
Policy, Guidance Note
Organization / Institution:
Foundation Home Loans
Author:
Foundation Home Loans
Target Audience:
Legal Advisors, Borrowers, Guarantors
Effective Period:
During UK Government Covid-19 movement restrictions
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2025
Region / City:
Wuhan, CN
Topic:
Ambient IoT, AIoT Device Characteristics
Document Type:
Technical Proposal
Author:
Huawei, HiSilicon
Target Audience:
Technical experts, 3GPP working groups
Effective Period:
2025
Approval Date:
N/A
Amendment Date:
N/A
Year:
2024
Region / City:
United States
Topic:
Disability Accommodation
Document Type:
Policy
Authority:
Executive Order 13164, Executive Order 14035, Rehabilitation Act of 1973, ADAAA
Target Audience:
Federal employees, applicants with disabilities
Period of Effectiveness:
Ongoing
Approval Date:
April 2024
Date of Changes:
April 2024
Note:
Context